NCT06239259

Validity and Reliability of Thai Version of Kamath and Stothard Clinical Questionnaire for Diagnosis of Carpal Tunnel Syndrome

Siriraj Hospital·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Carpal Tunnel Syndrome
Drug/Device/Intervention
Questionare As described in Secondary Outcomes
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Siriraj Hospital
Location
Bangkok Noi, Thailand
Timeline & enrollment
Phase
N/A
Start date
Jul 06, 2023
End date
Feb 28, 2025
Enrollment
80 participants
Primary outcome

Validity of Thai version of Kamath and Stothard Quesionaire in carpal tunnel syndrome patients,Releability of Thai version of Kamath and Stothard Quesionaire in carpal tunnel syndrome patients

Summary

The Kamath and Stothard clinical questionnaire for diagnosing carpal tunnel syndrome (CTS) is
 a valid score for diagnosis of CTS. However it haven't been translated in to Thai version and
 the validity and accuracy of the Thai the Thai version have not been yet verified.
 
 The research team recognizes the importance and potential benefits of adapting this
 assessment for use within the Thai population.Therefore, we aim to conduct this research to
 translate the questionnaire from the original English to Thai and to assess its validity and
 reliability for diagnosing patients with Carpal Tunnel Syndrome.

ICD-10 classifications
Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06239259
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06239259 through Pure Global AI's free database. This phase not specified trial is sponsored by Siriraj Hospital and is currently Recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.